A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study
Sonya Stacey, Jamie Lam, Fiona Gregory, Shakira Wild, Steven McTaggart, Helen Irving · 2026
Read A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study by Sonya Stacey, Jamie Lam, Fiona Gregory, Shakira Wild, Steven McTaggart, Helen Irving (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617224.txt.
Description
Sonya Stacey and five colleagues report a 2026 Australian project to govern innovative medicines for children, meaning promising new drugs used before the usual evidence and approval pathways are complete. Such treatments can help rare or untreatable conditions, yet they raise safety, cost, and fairness questions. The team combined an expert consensus process, a hospital records review, and an adapted ethical framework from the United Kingdom.
Eighteen Australian paediatric experts agreed a working definition after four feedback rounds. Reviewing nearly three thousand medication approval applications at a tertiary children's hospital found one hundred twenty requests for drugs not on the national register. Just six counted as innovative under the new definition. The authors say the framework gives hospitals a practical tool to judge these requests consistently while protecting young patients.
Catalog record
| CREATOR | Sonya Stacey, Jamie Lam, Fiona Gregory, Shakira Wild, Steven McTaggart, Helen Irving |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |